.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The National Institute of Technology, Rourkela (NITR) has introduced a breakthrough 3D bioprinting bio-ink for advanced tissue engineering applications. This novel material aims to solve common challenges in regenerative medicine, such as poor mechanical strength and low printability. Consequently, researchers have created a protein-polysaccharide composite that offers high shape fidelity. This advancement could transform how surgeons approach complex bone and cartilage repairs in the near future.
The NITR team, led by Associate Professor Devendra Verma, utilized a specific blend of biomaterials to create this technology. They combined bovine serum albumin (BSA) with sodium alginate and polyelectrolyte complexes of gelatin and chitosan (PEC-GC). Notably, this combination creates a bioactive system that supports rapid cell growth. Furthermore, the material maintains its structural integrity throughout the entire printing process. Therefore, the resulting scaffolds provide a stable environment for tissue regeneration without losing their anatomical shape.
Laboratory trials demonstrate that the bio-ink effectively mimics the extracellular matrix of bone tissue. This mimicry promotes essential biological responses, including cell adhesion and proliferation. Specifically, experiments involving 2% PEC-GC scaffolds achieved over 90% cell viability. Moreover, these scaffolds showed significant potential for collagen synthesis and bone tissue formation. Such precision allows for the fabrication of patient-specific structures with exact geometries. Consequently, the team plans to move toward animal and clinical studies to validate these findings for human use soon.
Q1: What makes the NITR bio-ink different from existing options?
The NITR bio-ink bridges the gap between printability and biological performance by using nanofibrous complexes. This allows for high-precision printing while actively supporting cellular functions and tissue regeneration.
Q2: For which medical conditions is this bio-ink most suitable?
Currently, the developed technology shows high efficacy for bone and cartilage repair. It allows for the creation of patient-specific scaffolds that mimic the mechanical and biological properties of these specific tissues.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
NIT Rourkela researchers developed a 3D bioprinting bio-ink for bone and cartilage repair, offering high shape fidelity and over 90% cell viability in trial...
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
